BlueGnome Enters 'Emerging and Significant' Chinese Market

CEO Nick Haan said China is an attractive market because BlueGnome's pre-implantation genetic-screening products could make a strong showing there, and because its 1.3 billion-person population is becoming "increasingly affluent."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.